FDA approved
A designation indicating the U.S. Food and Drug Administration has determined a drug is safe and effective for its labeled indication based on clinical trial evidence. FDA-approved peptides include semaglutide, tirzepatide, liraglutide, and PT-141.
Frequently Asked Questions
What is FDA approved?
Why is FDA approved important in peptide research?
Related Terms
The formal application to the FDA requesting approval to market a new drug. Contains all clinical trial data, manufacturing details, and proposed labeling. Review takes 6–12 months.
BLA (biologics license application)The regulatory pathway for approval of biological products (including some peptides and proteins) by the FDA. Similar to an NDA but specifically for biologics derived from living organisms.
Clinical trial phasesThe staged process of testing a new drug in humans: Phase 1 (safety), Phase 2 (efficacy), Phase 3 (large-scale confirmation), and Phase 4 (post-marketing surveillance). Each phase has specific objectives and requirements.
Related Peptide Profiles
A GLP-1 receptor agonist FDA-approved for type 2 diabetes (Ozempic) and weight management (Wegovy). Reduces appetite and slows gastric emptying.
TirzepatideA dual GIP/GLP-1 receptor agonist FDA-approved for type 2 diabetes (Mounjaro) and weight loss (Zepbound). Achieves 20–25% body weight reduction in clinical trials.
LiraglutideA GLP-1 receptor agonist FDA-approved for type 2 diabetes (Victoza) and weight management (Saxenda). Administered as a daily injection.
PT-141Bremelanotide, a melanocortin receptor agonist FDA-approved as Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women.